Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Minaprine in depression. A controlled trial with amitriptyline.

D Wheatley1

  • 1Psychopharmacology Research Group, Cobham, Surrey.

The British Journal of Psychiatry : the Journal of Mental Science
|July 1, 1992
PubMed
Summary

Minaprine and amitriptyline effectively treated major depression over six weeks. Minaprine showed fewer side effects like drowsiness and dry mouth compared to amitriptyline.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extended follow-up of palbociclib with fulvestrant or letrozole for endocrine-sensitive, hormone receptor-positive/HER2-negative advanced breast cancer in the PARSIFAL trial.

ESMO open·2025
Same author

Regional Lymph Node Delineation variability and its Dosimetric Impact in Breast Cancer Radiotherapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Counterpoint: Does Mastectomy Reduce Overall Survival in Early Stage Breast Cancer?

Clinical oncology (Royal College of Radiologists (Great Britain))·2021
Same author

Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK.

Clinical oncology (Royal College of Radiologists (Great Britain))·2020
Same author

Breast radiotherapy: less is more?

Clinical oncology (Royal College of Radiologists (Great Britain))·2012

Area of Science:

  • Psychiatry and Clinical Pharmacology
  • Neuroscience

Background:

  • Major depression is a prevalent and debilitating mood disorder.
  • Pharmacological interventions are a cornerstone of depression treatment.
  • Amitriptyline is a commonly prescribed tricyclic antidepressant.

Purpose of the Study:

  • To compare the efficacy and tolerability of minaprine versus amitriptyline in patients with major depression.
  • To evaluate the impact of different minaprine dosing regimens (once daily vs. divided twice daily) on treatment outcomes.

Main Methods:

  • A randomized controlled trial involving 144 patients diagnosed with major depression.
  • Treatment duration was six weeks.
  • Hamilton Rating Scale for Depression (HRSD) scores were used to assess depressive symptom severity.
  • Incidence of adverse events, specifically drowsiness and dry mouth, was recorded.

Main Results:

  • Both minaprine (200 mg daily) and amitriptyline (25-50 mg t.d.s.) demonstrated significant reductions in HRSD scores.
  • No statistically significant differences in antidepressant efficacy were observed between minaprine and amitriptyline.
  • Amitriptyline was associated with a significantly higher incidence of drowsiness and dry mouth compared to minaprine.

Conclusions:

  • Minaprine is an effective treatment for major depression, comparable in efficacy to amitriptyline.
  • Minaprine offers a potentially better tolerability profile, with a lower incidence of common anticholinergic side effects.
  • Further research may explore optimal dosing strategies and long-term outcomes for minaprine in depression management.

Related Experiment Videos